ArticlesFull Access
Published Online:24 Aug 2022https://doi.org/10.1176/appi.ajp.21050485
- Cited by
- Jeremy Veenstra-VanderWeele,
M.D. , - Kally C. O’Reilly,
Ph.D. , - Megan Y. Dennis,
Ph.D. , - José M. Uribe-Salazar,
Ph.D. , - David G. Amaral,
Ph.D.
1 April 2023 | American Journal of Psychiatry, Vol. 180, No. 4- Jeremy Veenstra-VanderWeele,
- Matthew D. Lerner,
Ph.D. , - Talena C. Day,
M.A.
1 January 2023 | American Journal of Psychiatry, Vol. 180, No. 1- Matthew D. Lerner,
- Ned H. Kalin,
M.D.
1 January 2023 | American Journal of Psychiatry, Vol. 180, No. 1- Ned H. Kalin,
- 6 December 2022 | ACS Chemical Neuroscience, Vol. 13, No. 24
- 29 October 2022 | Molecular Autism, Vol. 13, No. 1
- 1 January 2022 | Spectrum
Metrics
Important contributions were provided by members of the Autism Biomarkers Consortium for Clinical Trials (ABC-CT), including Madeline Aubertine, Cynthia Brandt, Shou-An A. Chang, Kelsey Dommer, Alyssa Gateman, Simone Hasselmo, Julie Holub, Toni Howell, Ann Harris, Alexander Hoslet, Kathryn Hutchins, Kelsey Jackson, Scott Johnson, Lily Katsovitch, Minah Kim, Beibin Li, Samantha Major, Samuel Marsan, Andriana S. Méndez Leal, Lisa Nanamaker, Leon Rozenblit, Laura Simone, Dylan Stahl, Cindy Voghell, Andrew Yuan. Consultation was provided by the EU Aims Longitudinal European Autism Project team, including Declan Murphy, Eva Loth, Emily J.H. Jones, and Luke Mason.
History
Received 12 May 2021
Revised 14 March 2022
Accepted 2 May 2022
Published online 24 August 2022
Published in print 1 January 2023
![Loading](/specs/libraries/ui-core/releasedAssets/images/spinner-6fdf6f7f6e2cdc0643c07483defc3379.gif)